Structure-Based Drug Design for Targeting RNA: Preclinical Validation

Time: 9:50 am
day: Day One

Details:

  • Expansion repeat disorders: unmet medical need
  • Drugging RNA using structure-informed design
  • Preclinical validation of this approach

Speakers: